FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Realm US

18,400 resources

Type: Text:

By Version

By Authority

 

Start Prev Rows 5600 - 5800 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3424Hemodialysis Contact Type Hepatitis (NETSS)active2011-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3432Serogroup (NETSS)active2011-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3434Antimicrobial Agent NETSSactive2011-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3435Serotype (NETSS)active2011-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.5000Universal Identifier (HL7) (PHLIP)active2011-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.5002Order Control Codes (HL7) (PHLIP)active2011-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.5004Specimen Reject Reason (SCT) (PHLIP)active2011-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.5005Lab Test Order (PHLIP Sal)active2011-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.5006Value Type (HL7) (PHLIP)active2011-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.5007Specimen Related Observations (PHLIP Sal)active2011-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.5013Suspected Agent (PHLIP Sal)active2011-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.5014Observation Result Status (PHLIP)active2011-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6067Universal ID Type (ELR)active2012-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6069NAACCR ICD-10-CM Cancer Reportability Listactive2012-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6072Trachoma (NCHS)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7154Fetal Presentation at Birth- Unknown (NCHS)active2014-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7188Travel Reason (Hepatitis A)active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7246Vital Signs (Syndromic Surveillance)active2014-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7247Symptoms (EVD Triage)active2014-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7248Countries Widespread Transmission (EVD)active2014-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7249Exposure Risk (EVD)active2014-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7250Observation Identifiers (EVD Triage)active2014-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7257Abdominal Pain (CDS - EHR)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7258Weakness (CDS - EHR)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7259Fever (CDS - EHR)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7260Headache (CDS - EHR)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7261Hemorrhage (CDS - EHR)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7262Muscle Pain (CDS - EHR)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7263Vomiting (CDS - EHR)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7264Diarrhea (CDS - EHR)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7275Nationally Notifiable Event Code (Hepatitis)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7331Vaccine Administered (MMR)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7339Lab Test Name (Chikungunya virus)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7340Lab Test Name (Junin Hemorrhagic fever)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7341Lab Test Name (Lassa fever)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7342Lab Test Name (Marburgvirus)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7343Lab Result (Chikungunya virus)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7344Lab Result (Crimean-Congo hemorrhagic fever)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7345Lab Result (Guanarito hemorrhagic fever)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7346Lab Result (Junin hemorrhagic fever)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7347Lab Result (Lassa fever)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7348Lab Result (Lujo virus)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7349Lab Result (Machupo hemorrhagic fever)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7350Lab Result (Sabia virus hemorrhagic fever)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7395System Reject Codes (NCHS)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7398Nationally Notifiable Event Code (Syphilis)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7402Patient Residence (NCHS)active2014-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7403Injury or Poisoning (NCHS)active2014-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7404Major reason for visit (NCHS)active2014-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7405Co-morbid Conditions (NCHS)active2014-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7419Provider ED (NCHS)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7433Condition Control (NCHS)active2014-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7436Disposition (NCHS)active2014-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7439Episode of Care (NCHS)active2014-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7440Hospital Discharge Status (NCHS)active2014-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7478Serotype (Dengue)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7479Lab Result (Zika virus)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7515Data Elements (NND Hep Core)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7516Data Elements (NND Hep A Acute)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7517Data Elements (NND Hep B Acute)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7518Data Elements (NND Hep B Perinatal)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7519Data Elements (NND Hep B Chronic)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7520Data Elements (NND Hep C Acute)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7521Data Elements (NND Hep C Chronic)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7522Data Elements (NND Mumps)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7523Data Elements (NND Pertussis)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7524Data Elements (NND STD)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7618Yes No Unknown Refused (NND)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7622Positive Negative Not Doneactive2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7628Yes No Unknown Maybe (FDD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7629Yes No Don't Know Maybe (FDD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7648Yes No Not Tested (NND)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8065Occupation CDC Census 2018active2022-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8066Industry CDC Census 2018active2022-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8067Industry CDC NAICS 2017active2022-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8068Occupation CDC SOC 2018active2022-01
signal.core.r4R4ValueSet/2.16.840.1.113762.1.4.1021.32Gender Identityactive2022-03hl7
us.nlm.vsacR4ValueSet/1.2.91.13925.17760.1280649Sneezing and Itching Groupingactive2017-06
us.nlm.vsacR4ValueSet/1.2.91.13925.17760.15972546Conditions Indicating Appropriate Sinonasal Imagingactive2017-06
us.nlm.vsacR4ValueSet/1.2.91.13925.17760.16432390Cerumen Impactionactive2017-06
us.nlm.vsacR4ValueSet/1.2.91.13925.17760.16929355Allergic Rhinitis Groupingactive2017-06
us.nlm.vsacR4ValueSet/1.2.91.13925.17760.18316962Severe Asthmaactive2017-06
us.nlm.vsacR4ValueSet/1.2.91.13925.17760.19613338Immunoglobulin G Testing Groupingactive2022-03
us.nlm.vsacR4ValueSet/1.2.91.13925.17760.23618223Hearing Aids Groupingactive2017-06
us.nlm.vsacR4ValueSet/1.2.91.13925.17760.24927846Specific IgE testingactive2017-06
us.nlm.vsacR4ValueSet/1.2.91.13925.17760.26050446Ear Surgery Affecting the Tympanic Membraneactive2017-06
us.nlm.vsacR4ValueSet/1.2.91.13925.17760.26878039Specific IgE Testingactive2022-03
us.nlm.vsacR4ValueSet/1.2.91.13925.17760.29996863Immunoglobulin G testingactive2017-06
us.nlm.vsacR4ValueSet/1.2.91.13925.17760.4352590Benign Prostatic Hyperplasiaactive2017-08
us.nlm.vsacR4ValueSet/1.2.91.8867.26816.649902Office or Outpatient Encounteractive2017-07
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.33895.1.3.0.45Comfort Measuresactive2021-02hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.18.1.1.11.1.999.1pain medication action planactive2015-08hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.3.2All prescribable opioids used for pain control including Inactive Medicationsactive2015-08hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.1malignant neoplasms and cancer painactive2015-08hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.2malignant neoplasms and cancer painactive2015-08hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.7malignant neoplasms and cancer painactive2015-08hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.9malignancy or cancer related painactive2015-08hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.150Cerumen on Otoscopyactive2017-02hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.151Cerumen on Otoscopyactive2017-02hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.152Cerumen on Otoscopyactive2017-02hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.172Hearing Lossactive2017-02hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.173Hearing Lossactive2017-02hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.174Hearing Lossactive2017-02hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.175Tinnitusactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.176Tinnitusactive2017-02hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.177Tinnitusactive2017-02hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.14.1.999.178Ear Congestionactive2017-02hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.15.1.999.179Ear Pruritusactive2017-02hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.180Otalgiaactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.181Otalgiaactive2017-02hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.182Otalgiaactive2017-02hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31441.1.2.999.96Initial Encounter with Otolaryngologist or undefined clinicianactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.204Hearing Aidsactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.205Hearing Aidsactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.206Hearing Aidsactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.81Cerumen Impactionactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.82Cerumen Impactionactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.190Radiotherapyactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.191Head and Neck Anatomic Locationsactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.192Conditions Associated with Head and Neck Radiotherapyactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.194Ear Canal Stenosisactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.195Ear Canal Stenosisactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.196Ear Canal Stenosisactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.197Exostosesactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.198Exostosesactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.199Exostosesactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.200Non intact Tympanic Membraneactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.201Non Intact Tympanic Membraneactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.202Non Intact Tympanic Membraneactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.246Hearing Aidsactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.250DO NOT USEactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.251Cerumenolyticsactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.252Irrigationactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.253Irrigationactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31593.1.12.1.999.288Otoscopy performed on examactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31663.1.1.999.291Otolaryngologist as a Clinician or Serviceactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.8.31102.1.1.999.123Cerumen Impactionactive2017-02hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31104.1.1.999.275Dermatologic Diseases of the Earactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31108.1.1.999.20Keratoses Obturansactive2017-02hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.221Tympanoplastyactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.222Tympanoplastyactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.223Myringoplastyactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.224Myringoplastyactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.225Mastoidectomyactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.229Mastoidectomyactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.227Ear Surgery, Otheractive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.228Ear Surgery, Otheractive2018-01hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.334Sleep Apneaactive2018-05hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.336Sleep Apneaactive2018-05hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.237Allergic Rhinitisactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.238Allergic Rhinitisactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.239Allergic Rhinitisactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.263Uncontrolled or severe asthmaactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.264Uncontrolled or severe asthmaactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.265Uncontrolled or severe asthmaactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.300Rhinosinusitisactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.301Rhinosinusitisactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.302Rhinosinusitisactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.303Nasal Polyposisactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.304Nasal Polyposisactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.305Nasal Polyposisactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.306Suspected Nasal Neoplasmactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.307Suspected Nasal Neoplasmactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.308Suspected Nasal Neoplasmactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.309Other sinus conditions potentially requiring imagingactive2017-08hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.310Other sinus conditions potentially requiring imagingactive2017-08hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.11.1.999.319Intranasal Antihistaminesactive2017-06hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.12.1.999.320Mast Cell Stabilizersactive2017-06hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.13.1.999.321Ophthalmic Antihistaminesactive2017-06hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.215Sneezing as a findingactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.216Sneezing as a Clinical Conditionactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.217Pruritus Unspecified or Other Locationactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.218Pruritus Unspecified or Other Locationactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.11.1.999.272Specific IgE Testing for Allergiesactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.12.1.999.273Immunoglobulin G Testingactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.13.1.999.274Total IgE Testingactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34920.1.1.999.290Clinicians who perform allergy testingactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35043.1.1.999.279Radiography of face, head or neckactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.11.1.999.315Intranasal Corticosteroidsactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.316Eustachian Tube Dysfunctionactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.317Eustachian Tube Dysfunctionactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.318Eustachian Tube Dysfunctionactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35292.1.1.999.287Oral Second Generation and Less Sedating Antihistaminesactive2017-05hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35464.1.1.999.266Leukotriene antagonistactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.11.1.999.267Immunotherapy that is not Identified as Subcutaneousactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.14.1.999.268Immunotherapyactive2017-03hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.271.12.37641.1.1.999.653Fidaxomicinactive2019-04hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.655Clostridium difficile infectionactive2019-04hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.656Clostridium difficile infectionactive2019-04hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.657Clostridium difficile infectionactive2019-04hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38167.1.1.999.594Complete Blood Count (with Diff)active2019-04hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38256.1.1.999.662Metronidazole Systemicactive2019-04hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38266.1.1.999.663Vancomycin non injectableactive2019-04hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38343.1.1.999.665Creatinineactive2019-04hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.722Ileus due to infectionactive2019-04hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.723Ileus due to infectionactive2019-04hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.724Ileus due to infectionactive2019-04hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.725Vomiting potentially due to CDIactive2019-04hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.726Vomiting potentially due to CDIactive2019-04hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.727Vomiting potentially due to CDIactive2019-04hl7